as on September 17, 2025 at 1:29 am IST
Day's Low
Day's High
1.17%
Downside
0.69%
Upside
52 Week's Low
52 Week's High
16.49%
Downside
6.39%
Upside
Check Abbott Laboratories market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$232.8B
EPS (TTM)
5.143
Dividend Yield
1.90%
Quarterly Earnings Growth YOY
0.36%
PE Ratio (TTM)
16.77
Industry PE ratio
16.65525641025641
P/B Ratio
16.7727
PEG Ratio
4.1675
EBITDA
11.5B
Revenue (TTM)
43.1B
Profit Margin
32.43%
Return On Equity TTM
30.93%
Track how Abbott Laboratories P/E has moved over time to understand its valuation trends.
Abbott Laboratories in the last 5 years
Lowest (18.93x)
September 30, 2022
Industry (16.66x)
September 16, 2025
Today (16.77x)
September 16, 2025
Highest (32.21x)
September 30, 2020
Today’s Price to Earnings Ratio: 16.77x
Compare market cap, revenue, PE, and other key metrics of Abbott Laboratories with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $232.8B | 24.25% | 16.77 | 32.43% | |
BUY | $428.8B | 19.54% | 19.05 | 25.00% | |
HOLD | $136.3B | -34.83% | 12.62 | 16.84% |
The Abbott Laboratories stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Abbott Laboratories investment value today
Current value as on today
₹1,17,721
Returns
₹17,721
(+17.72%)
Returns from Abbott Laboratories Stock
₹12,854 (+12.85%)
Dollar Returns*
₹4,867 (+4.87%)
Based on 29 analysts
75.86%
Buy
24.14%
Hold
0.00%
Sell
Based on 29 analysts, 75.86% of analysts recommend a 'BUY' rating for Abbott Laboratories. Average target price of $142.48
Get share price movements and forecasts by analysts on Abbott Laboratories.
What analysts predicted
6.83%UPSIDE
Target Price
$142.48
Current Price
$132.75
Analyzed by
29 Analysts
Target
$142.48
Abbott Laboratories target price $142.48, a slight upside of 6.83% compared to current price of $132.75. According to 29 analysts rating.
Investment in Abbott Laboratories Shares on INDmoney has dropped by -57.08% over the past 30 days, indicating reduced transactional activity.
Time period: to
Search interest for Abbott Laboratories Stock has decreased by -32% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Check out the Mutual Funds with significant holdings in Abbott Laboratories.
Today's Timeline - 09 September
Tue, 05:30 PM
-Investing in Abbott five years ago yielded a 37% total return; recent performance falls short of market return.
Tue, 09:30 PM
-Abbott's shares outperform industry; strong pipeline supports growth outlook for 2025 despite COVID-19 testing sales decline.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
Abbott Laboratories has shown strong profit growth over the last two quarters. In the first quarter, their net profit was $1.32 billion, and it increased to $1.77 billion in the second quarter. This represents an average increase of 25.5% in profit per quarter.
Revenue Rich
Abbott Laboratories has shown positive revenue growth over the last two quarters. The company's revenue increased from $10.35 billion to $11.14 billion, reflecting an average growth rate of 7.0% per quarter.
Best in 1 Year
In the last 1 year, ABT has outperformed top 5 stocks with highest market-cap in its industry
Best in 3 Years
In the last 3 years, ABT has outperformed top 5 stocks with highest market-cap in its industry
Price Dip
In the last 7 days, ABT stock has moved down by -0.5%
Organisation | Abbott Laboratories |
Headquarters | 100 Abbott Park Road, North Chicago, IL, United States, 60064-6400 |
Industry | Health Technology |
CEO | Mr. Robert B. Ford |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Mr. Michael Comilla | Vice President of Investor Relations. |
Erica L. Battaglia | VP and Chief Ethics & Compliance Officer |
Ms. Mary K. Moreland | Executive Vice President of Human Resources |
Ms. Melissa Brotz | Senior Vice President of Global Marketing & External Affairs |
Mr. Robert B. Ford | Chairman of the Board, President & CEO |
Mr. Daniel Gesua Sive Salvadori | Executive VP and Group President of Established Pharmaceuticals & Nutritional Products |
Ms. Sabina Ewing | Senior VP of Business & Technology Services and Chief Information Officer |
Mr. Philip P. Boudreau | CFO & Executive VP of Finance |
Ms. Lisa D. Earnhardt | Executive VP & Group President of Medical Devices |
Ms. Elizabeth Cushman | Executive VP, General Counsel & Secretary |
Abbott Laboratories share price today is $132.75 as on at the close of the market. Abbott Laboratories share today touched a day high of $133.66 and a low of $131.2.
Abbott Laboratories share touched a 52 week high of $141.23 on and a 52 week low of $110.86 on . Abbott Laboratories stock price today i.e. is closed at $132.75,which is 6.00% down from its 52 week high and 19.75% up from its 52 week low.
Abbott Laboratories market capitalisation is $0.23T as on .
Indian investors can start investing in Abbott Laboratories (ABT) shares with as little as ₹88.042 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹880.42 in Abbott Laboratories stock (as per the Rupee-Dollar exchange rate as on ).
Based on Abbott Laboratories share’s latest price of $132.75 as on September 17, 2025 at 1:29 am IST, you will get 0.0753 shares of Abbott Laboratories. Learn more about
fractional shares .
Abbott Laboratories stock has given 24.25% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?